S M Verma1, J Okawa, K J Propert, V P Werth. 1. Department of Dermatology, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, U.S.A; Department of Dermatology, University of Pennsylvania, Philadelphia, PA, U.S.A.
Abstract
BACKGROUND: Patients with more severe cutaneous lupus erythematosus (CLE) have a poorer quality of life (QoL). Racial and ethnic disparities have been reported in disease activity and outcomes in systemic lupus erythematosus, but similar information is not available for CLE. OBJECTIVES: To evaluate the impact of lupus-related skin damage on skin-specific QoL, and to analyse differences stratified by ethnic background. METHODS: Data collected included sex, race, diagnosis and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and Skindex-29 scores. These parameters were analysed at the initial and last visits. CLASI damage scores (dyspigmentation and scarring) and activity scores were collected, grouped by ethnicity, and correlated with Skindex-29. Overall, 223 patients were analysed at baseline, with 141 completing more than one study visit. RESULTS: The majority of patients were white (63·7%), followed by African American (29·1%) and Asian American (4·0%). African American patients accounted for a disproportionate percentage of both localized (50%) and generalized discoid lupus erythematosus (DLE) (49%). Median CLASI damage scores differed significantly between the African American, white and Asian American patients, at both the first (8·5, 4·0, 7·0, respectively; P < 0·0001) and last visit (10·0, 6·0, 8·5, respectively; P < 0·01). CLASI damage scores in African Americans correlated with CLASI activity scores (Spearman r = 0·45, P = 0·0003). CONCLUSIONS: There was no significant correlation between CLASI damage scores and Skindex domains overall. Individually, dyspigmentation and scarring also did not have a significant effect on QoL. Ethnic differences in patients with CLE were found: African American patients exhibited a high rate of DLE and experienced damage early in their disease course, frequently in conjunction with disease activity. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND:Patients with more severe cutaneous lupus erythematosus (CLE) have a poorer quality of life (QoL). Racial and ethnic disparities have been reported in disease activity and outcomes in systemic lupus erythematosus, but similar information is not available for CLE. OBJECTIVES: To evaluate the impact of lupus-related skin damage on skin-specific QoL, and to analyse differences stratified by ethnic background. METHODS: Data collected included sex, race, diagnosis and Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and Skindex-29 scores. These parameters were analysed at the initial and last visits. CLASI damage scores (dyspigmentation and scarring) and activity scores were collected, grouped by ethnicity, and correlated with Skindex-29. Overall, 223 patients were analysed at baseline, with 141 completing more than one study visit. RESULTS: The majority of patients were white (63·7%), followed by African American (29·1%) and Asian American (4·0%). African American patients accounted for a disproportionate percentage of both localized (50%) and generalized discoid lupus erythematosus (DLE) (49%). Median CLASI damage scores differed significantly between the African American, white and Asian American patients, at both the first (8·5, 4·0, 7·0, respectively; P < 0·0001) and last visit (10·0, 6·0, 8·5, respectively; P < 0·01). CLASI damage scores in African Americans correlated with CLASI activity scores (Spearman r = 0·45, P = 0·0003). CONCLUSIONS: There was no significant correlation between CLASI damage scores and Skindex domains overall. Individually, dyspigmentation and scarring also did not have a significant effect on QoL. Ethnic differences in patients with CLE were found: African American patients exhibited a high rate of DLE and experienced damage early in their disease course, frequently in conjunction with disease activity. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Authors: I Moldovan; E Katsaros; F N Carr; D Cooray; K Torralba; S Shinada; M L Ishimori; M Jolly; D J Wallace; M H Weisman; P M Nicassio Journal: Lupus Date: 2011-08-03 Impact factor: 2.911
Authors: Joerg Albrecht; Lynne Taylor; Jesse A Berlin; Samuel Dulay; Gina Ang; Steven Fakharzadeh; Jonathan Kantor; Ellen Kim; Giuseppe Militello; Karen McGinnis; Stephen Richardson; James Treat; Carmela Vittorio; Abby Van Voorhees; Victoria P Werth Journal: J Invest Dermatol Date: 2005-11 Impact factor: 8.551
Authors: Guillermo J Pons-Estel; Graciela S Alarcón; Luis A González; Jie Zhang; Luis M Vilá; John D Reveille; Gerald McGwin Journal: Arthritis Care Res (Hoboken) Date: 2010-03 Impact factor: 4.794
Authors: Mónica Fernández; Graciela S Alarcón; Jaime Calvo-Alén; Rosa Andrade; Gerald McGwin; Luis M Vilá; John D Reveille Journal: Arthritis Rheum Date: 2007-05-15
Authors: F Sampogna; D Raskovic; L Guerra; C Pedicelli; S Tabolli; L Leoni; L Alessandroni; D Abeni Journal: Br J Dermatol Date: 2008-06-28 Impact factor: 9.302
Authors: Elizabeth Gaines; Zuleika Bonilla-Martinez; Joerg Albrecht; Lynne Taylor; Joyce Okawa; Andrea B Troxel; Victoria P Werth Journal: Arch Dermatol Date: 2008-08
Authors: M S Krathen; J Dunham; E Gaines; J Junkins-Hopkins; E Kim; S L Kolasinski; C Kovarik; J Kwan-Morley; J Okawa; K Propert; N Rogers; M Rose; P Thomas; A B Troxel; A Van Voorhees; J Von Feldt; A L Weber; V P Werth Journal: Arthritis Rheum Date: 2008-03-15
Authors: Jennifer Hong; Laura Aspey; Gaobin Bao; Tamara Haynes; S Sam Lim; Cristina Drenkard Journal: Am J Clin Dermatol Date: 2019-06 Impact factor: 7.403